Full Text | PDF

Share on facebook Share on tweeters Share on linkedin Share on googleplus

Theranostics 2020; 10(8):3722-3736. doi:10.7150/thno.42008 This issue Cite

Research Paper

Stepwise targeting and responsive lipid-coated nanoparticles for enhanced tumor cell sensitivity and hepatocellular carcinoma therapy

Ying Li1, Yunqiu Miao2,3, Mingshu Chen2,3, Xi Chen2, Feifei Li2, Xinxin Zhang2✉, Yong Gan2

1. Department of Pharmacy, School of Medicine, Shenzhen University, Shenzhen 518060, China
2. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China
3. School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

✉ Corresponding author: Xinxin Zhang, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China. Email: xinxinzhangac.cn

Citation:
Li Y, Miao Y, Chen M, Chen X, Li F, Zhang X, Gan Y. Stepwise targeting and responsive lipid-coated nanoparticles for enhanced tumor cell sensitivity and hepatocellular carcinoma therapy. Theranostics 2020; 10(8):3722-3736. doi:10.7150/thno.42008. https://www.thno.org/v10p3722.htm
Other styles

File import instruction

Abstract

Graphic abstract

Rationale: Antitumor drug delivery faces multiple barriers that require consecutively achieving tumor targeting, selective cellular uptake and sufficient intracellular drug dosage.

Methods: Herein, we designed smart nanoparticles (GPDC-MSNs) that can accumulate stepwise in tumor tissues, selectively enter cancer cells by responding to the acidic tumor extracellular environment, and achieve considerable drug release in the intracellular microenvironment. The GPDC-MSNs comprise the synthesized material galactosyl-conjugated PEO-PPO-PEO (Gal-P123) for hepatocellular carcinoma (HCC) targeting, the tumor extracellular pH-responsive lipid (2E)-4-(dioleostearin)-amino-4-carbonyl-2-butenonic (DC) for selective cellular internalization, and antitumor drug irinotecan (CPT-11)-loaded mesoporous silica nanoparticles (MSNs) for on-demand intracellular drug release.

Results: GPDC-MSNs are negatively charged at pH 7.4 and promote active HCC targeting mediated by the asialoglycoprotein receptor. Upon reaching the weakly acidic tumor microenvironment, the nanoparticles undergo charge conversion to neutral, enhancing cellular internalization. Moreover, the encapsulated CPT-11 can be retained within GPDC-MSNs in the blood circulation but undergo intracellular burst release, which facilitates the apoptosis of tumor cells. GPDC-MSNs significantly increased HCC selectivity in vivo and exhibited up to 25 times higher accumulation in tumor tissue than in normal hepatic tissue, thus achieving superior antitumor efficacy and low systemic toxicity.

Conclusion: This stepwise-responsive nanoparticle should serve as a valuable platform and promising strategy for HCC treatment.

Keywords: drug delivery, pH sensitive, charge conversion, tumor targeting, hepatocellular carcinoma

Citation styles

APA
Li, Y., Miao, Y., Chen, M., Chen, X., Li, F., Zhang, X., Gan, Y. (2020). Stepwise targeting and responsive lipid-coated nanoparticles for enhanced tumor cell sensitivity and hepatocellular carcinoma therapy. Theranostics, 10(8), 3722-3736. https://doi.org/10.7150/thno.42008.

ACS
Li, Y.; Miao, Y.; Chen, M.; Chen, X.; Li, F.; Zhang, X.; Gan, Y. Stepwise targeting and responsive lipid-coated nanoparticles for enhanced tumor cell sensitivity and hepatocellular carcinoma therapy. Theranostics 2020, 10 (8), 3722-3736. DOI: 10.7150/thno.42008.

NLM
Li Y, Miao Y, Chen M, Chen X, Li F, Zhang X, Gan Y. Stepwise targeting and responsive lipid-coated nanoparticles for enhanced tumor cell sensitivity and hepatocellular carcinoma therapy. Theranostics 2020; 10(8):3722-3736. doi:10.7150/thno.42008. https://www.thno.org/v10p3722.htm

CSE
Li Y, Miao Y, Chen M, Chen X, Li F, Zhang X, Gan Y. 2020. Stepwise targeting and responsive lipid-coated nanoparticles for enhanced tumor cell sensitivity and hepatocellular carcinoma therapy. Theranostics. 10(8):3722-3736.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use